During the past decade, Kansas City NCI Community Oncology Research Program conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 61 clinical trials were completed, i.e. on average, 610% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 33 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kansas City NCI Community Oncology Research Program" #1 sponsor was "National Cancer Institute (NCI)" with 48 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Gynecologic Oncology Group" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "GOG Foundation" with 3 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kansas City NCI Community Oncology Research Program" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Kansas City NCI Community Oncology Research Program" are "Stage IIIA Fallopian Tube Cancer AJCC v7" (6 trials), "Stage IIIB Fallopian Tube Cancer AJCC v7" (6 trials), "Stage IIIC Fallopian Tube Cancer AJCC v7" (6 trials), "Stage IV Fallopian Tube Cancer AJCC v6 and v7" (6 trials) and "Stage IV Ovarian Cancer AJCC v6 and v7" (6 trials). Many other conditions were trialed in "Kansas City NCI Community Oncology Research Program" in a lesser frequency.

Most popular intervention types in "Kansas City NCI Community Oncology Research Program" are "Drug" (63 trials), "Other" (63 trials), "Biological" (31 trials), "Procedure" (13 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (23 trials), "Paclitaxel" (13 trials), "Bevacizumab" (12 trials) and "Carboplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "Kansas City NCI Community Oncology Research Program" are 52 trials for "All" genders and 23 trials for "Female" genders.

Currently, there are NaN active trials in "Kansas City NCI Community Oncology Research Program". undefined are not yet recruiting, undefined are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Kansas City NCI Community Oncology Research Program, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kansas City NCI Community Oncology Research Program, 4 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".